Position in INCY
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$60,352,521
+$3,365,310 QoQ
Shares Held
532,397
-12.1% QoQ
Ownership
0.266%
of shares outstanding
% of Portfolio
0.02%
of 13F equity value
Holder Rank
#56
of 855 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 0%
Shared 90%
None 10%
Common Shares in INCY Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026AMERIPRISE FINANCIAL INC holds $5,060,262,064 across 202 Biotechnology names. INCY ranks #16 (1.2% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
2,604,822 | $1,293,893,227 | |
| 2 | INSM |
INSMED Inc
|
6,179,571 | $658,865,856 | |
| 3 | JAZZ |
Jazz Pharmaceuticals plc
|
1,215,523 | $292,904,576 | |
| 4 | RVMD |
Revolution Medicines, Inc.
|
1,039,702 | $194,715,388 | |
| 5 | ARGX |
Argenx SE
|
181,464 | $168,356,853 | |
| 6 | REGN |
Regeneron Pharmaceuticals, Inc.
|
227,457 | $141,828,535 | |
| 7 | MDGL |
Madrigal Pharmaceuticals, Inc.
|
231,205 | $124,145,521 | |
| 8 | BBIO |
BridgeBio Pharma, Inc.
|
1,551,663 | $115,567,858 |
All Filings in INCY
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $60,352,521 | 532,397 | Shares | Defined | 2026-08-14 | |
| 2026-03-31 | $56,987,211 | 605,474 | Shares | Defined | 2026-05-15 | |
| 2025-12-31 | $85,450,863 | 865,150 | Shares | Defined | 2026-02-17 | |
| 2025-09-30 | $49,593,748 | 584,763 | Shares | Defined | 2025-11-14 | |
| 2025-06-30 | $32,823,721 | 481,993 | Shares | Defined | 2025-08-14 | |
| 2025-03-31 | $29,404,531 | 485,624 | Shares | Defined | 2025-05-14 | |
| 2024-12-31 | $39,161,998 | 566,990 | Shares | Defined | 2025-02-14 | |
| 2024-09-30 | $49,111,770 | 742,992 | Shares | Defined | 2024-11-14 | |
| 2024-06-30 | $46,499,963 | 767,073 | Shares | Defined | 2024-08-14 | |
| 2024-03-31 | $48,797,365 | 856,545 | Shares | Defined | 2024-05-15 | |
| 2023-12-31 | $55,958,382 | 891,199 | Shares | Defined | 2024-02-14 | |
| 2023-09-30 | $53,839,674 | 931,966 | Shares | Defined | 2023-11-14 | |
| 2023-06-30 | $43,632,268 | 700,920 | Shares | Defined | 2023-08-14 | |
| 2023-03-31 | $44,006,067 | 608,912 | Shares | Defined | 2023-05-22 | |
| 2022-12-31 | $22,299,159 | 277,629 | Shares | Defined | 2023-02-14 | |
| 2022-09-30 | $15,360,186 | 230,495 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $18,197,927 | 239,541 | Shares | Defined | 2022-08-15 | |
| 2022-03-31 | $19,734,040 | 248,477 | Shares | Defined | 2022-05-16 | |
| 2021-12-31 | $14,940,055 | 203,543 | Shares | Defined | 2022-02-14 | |
| 2021-09-30 | $2,906,227 | 42,254 | Shares | Defined | 2021-11-15 | |
| 2021-06-30 | $4,021,076 | 47,796 | Shares | Defined | 2021-08-16 | |
| 2021-03-31 | $8,981,714 | 110,517 | Shares | Defined | 2021-05-17 | |
| 2020-12-31 | $10,599,728 | 121,864 | Shares | Defined | 2021-02-12 | |
| 2020-09-30 | $12,116,514 | 135,018 | Shares | Defined | 2020-11-16 | |
| 2020-06-30 | $5,847,895 | 56,246 | Shares | Defined | 2020-08-14 | |
| 2020-03-31 | $20,603,551 | 281,354 | Shares | Defined | 2020-05-15 | |
| No filing history on record for this holder in this stock. | ||||||